Osteopathic Treatment in Adult Patients With Cystic Fibrosis
NCT ID: NCT01293019
Last Updated: 2012-11-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
32 participants
INTERVENTIONAL
2009-11-30
2011-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental
Osteopathic treatment
Osteopathic treatment
Real treatment of osteopathy
Placebo
Sham osteopathic treatment
Sham Placebo
Sham treatment of osteopathy
Usual care
Classic treatment of cystic fibrosis patients
Usual care
Classical treatment of pain in cystic fibrosis patients
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Osteopathic treatment
Real treatment of osteopathy
Sham Placebo
Sham treatment of osteopathy
Usual care
Classical treatment of pain in cystic fibrosis patients
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age \> 18 years
* Patient with chronic chest , neck or back pain
* Written Informed Consent
* with health insurance
Exclusion Criteria
* patients awaiting lung transplantation
* history of lung transplantation
* pregnancy
* understanding disorders preventing the patient to apply the study
* participation in another clinical interventional study protocol
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Vaincre la Mucoviscidose
OTHER
Assistance Publique - Hôpitaux de Paris
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dominique Hubert, MD
Role: STUDY_CHAIR
Assistance Publique - Hôpitaux de Paris
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cochin Hospital
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Hubert D, Soubeiran L, Gourmelon F, Grenet D, Serreau R, Perrodeau E, Zegarra-Parodi R, Boutron I. Impact of osteopathic treatment on pain in adult patients with cystic fibrosis--a pilot randomized controlled study. PLoS One. 2014 Jul 16;9(7):e102465. doi: 10.1371/journal.pone.0102465. eCollection 2014.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P 080701
Identifier Type: -
Identifier Source: org_study_id